Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
about
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.CCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours.Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties.Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors.The spliceosome as target for anticancer treatment.Gastrin, inflammation, and carcinogenesis.Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumorsRadiolabelled peptides for oncological diagnosis.Molecular imaging probes derived from natural peptides.Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies.Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607.Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissueCharacterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors.
P2860
Q33915233-C117BC3F-0233-4B4A-8CD2-07365E0D7F9DQ33925682-B41F0CC1-651D-44DE-9A0F-641C079AC296Q34250142-6BCFA7CC-1801-4677-B562-1F05FA53E5FBQ34914935-7C386A3E-3DFB-41AD-9722-93180191C7F0Q35911669-612FFB88-F2CE-437E-ABA7-9839F5EC3959Q37278402-C9EA3FC2-6144-4669-85B0-75A58267A92BQ37335031-C12F36B5-C468-4C43-AF6B-5D1C053CE7D6Q37631370-E395A514-68CA-4BB3-9C3B-D8202DD226F3Q37701765-40666521-4222-4A6A-AD20-ED0DD0D2C39AQ37990405-05C4B193-75AB-4A16-A027-55EBF3D9F8B6Q38748846-EEBDE367-762D-4B3A-AAEE-8BCD10A24293Q39512185-14DF7763-C141-4D1C-A79A-1D32740C3CF8Q39552291-4D4C79E5-F057-41ED-A455-70F607D8C85DQ42069671-F3066EE3-8C43-4CEE-819D-025BF24B6BF4Q49266925-E918DC91-8FF8-4774-B0A9-42DA9B10D863
P2860
Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Targeting of a CCK(2) receptor ...... (111)In-labelled minigastrin.
@en
type
label
Targeting of a CCK(2) receptor ...... (111)In-labelled minigastrin.
@en
prefLabel
Targeting of a CCK(2) receptor ...... (111)In-labelled minigastrin.
@en
P2093
P50
P1476
Targeting of a CCK(2) receptor ...... (111)In-labelled minigastrin.
@en
P2093
Floris L van Delft
Floris P J T Rutjes
Jeseong Park
Marion de Jong
Mark R Hellmich
Martin Gotthardt
Susan Roosenburg
Wim J G Oyen
P2888
P304
P356
10.1007/S00259-007-0604-1
P577
2007-10-13T00:00:00Z